Literature DB >> 32936267

Myocardial Injury in COVID-19-Can We Successfully Target Inflammation?

Georgios Giannopoulos1, Dimitrios A Vrachatis2, Spyridon G Deftereos3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32936267     DOI： 10.1001/jamacardio.2020.2569

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  2 in total

Review 1.  Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Sotiria G Giotaki; Konstantinos Raisakis; Charalampos Kossyvakis; Andreas Kaoukis; Fotis Kolokathis; Gerasimos Deftereos; Konstantinos E Iliodromitis; Dimitrios Avramides; Harilaos Bogossian; Gerasimos Siasos; George Giannopoulos; Bernhard Reimers; Alexandra Lansky; Jean-Claude Tardif; Spyridon Deftereos
Journal:  J Clin Med       Date:  2021-10-31       Impact factor: 4.241

2.  Comment on: "Pharmaco-Immunomodulatory Therapy in COVID-19".

Authors:  Dimitrios A Vrachatis; Sotiria G Giotaki; George Giannopoulos; Spyridon Deftereos; Bernhard Reimers
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.